PIK3CA and ovarian cancer: Our results demonstrate for the first time that PI3K p110β-isoform is overexpressed in a subset of ovarian carcinoma samples, and that the selective inhibition of PI3K p110β sensitizes chemoresistant ovarian cancer cells to PTX.